1-8 of 8
Shlomo Elias
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of HBI0101, an Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for Relapsed/Refractory Multiple Myeloma

Eyal Lebel, Nathalie Asherie, Shlomit Kfir-Erenfeld, Shlomo Elias, Sigal Grisariu, Batia Avni, Miri Assayag, Tali Dubnikov-Sharon, Rivka Alexander-Shani, Nomi Bessig, Alaa Shehadeh, Aseel Ishtay, Shelly Pimienta, Vladimir Vaistein, Eran Zimran, Marjorie Pick, Yael C. Cohen, Irit Avivi Mazza, Cyrille Cohen, Polina Stepensky, Moshe E Gatt
Journal: Blood
Blood (2024) 144 (Supplement 1): 1030.
https://doi.org/10.1182/blood-2024-198225
Published: 2024
Journal Articles

Efficacy and Safety of Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for the Treatment of Relapsed and Refractory AL Amyloidosis

Eyal Lebel, Nathalie Asherie, Miri Assayag, Shlomo Elias, Sigal Grisariu, Batia Avni, Shlomit Kfir-Erenfeld, Tali Dubnikov-Sharon, Rivka Alexander-Shani, Nomi Bessig, Alaa Shehadeh, Aseel Ishtay, Shelly Pimienta, Vladimir Vaistein, Eran Zimran, Marjorie Pick, Yael C. Cohen, Irit Avivi Mazza, Cyrille Cohen, Polina Stepensky, Moshe E Gatt
Journal: Blood
Blood (2024) 144 (Supplement 1): 894.
https://doi.org/10.1182/blood-2024-198256
Published: 2024
Journal Articles

Feasibility of a Novel Academic Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis

Eyal Lebel, Shlomit Kfir-Erenfeld, Nathalie Asherie, Sigal Grisariu, Batia Avni, Shlomo Elias, Miri Assayag, Tatyana Dubnikov, Nomi Zalcman, Marjorie Pick, Eran Zimran, Yael C. Cohen, Irit Avivi Mazza, Cyrille Cohen, Polina Stepensky, Moshe E Gatt
Journal: Blood
Blood (2023) 142 (Supplement 1): 538.
https://doi.org/10.1182/blood-2023-186450
Published: 2023
Journal Articles

Safety and Efficacy of a Locally Produced Novel Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory Multiple Myeloma

Eyal Lebel, Nathalie Asherie, Shlomit Kfir-Erenfeld, Batia Avni, Sigal Grisariu, Shlomo Elias, Miri Assayag, Tatyana Dubnikov, Nomi Zalcman, Marjorie Pick, Eran Zimran, Yael C. Cohen, Irit Avivi Mazza, Cyrille Cohen, Moshe E Gatt, Polina Stepensky
Journal: Blood
Blood (2023) 142 (Supplement 1): 4852.
https://doi.org/10.1182/blood-2023-185069
Published: 2023
Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia

Shlomo Elias, Moneeza Walji, Samantha Brown, Sean M. Devlin, Esperanza B. Papadopoulos, Ann A Jakubowski, Doris M Ponce, James W. Young, Sergio A Giralt, Miguel-Angel Perales, Brian C. Shaffer, Parastoo B. Dahi, Richard J. Lin, Christina Cho, Roni Tamari, Melody Smith, Boglarka Gyurkocza
Journal: Blood
Blood (2022) 140 (Supplement 1): 10627–10628.
https://doi.org/10.1182/blood-2022-170088
Published: 2022
Journal Articles

The Oncogenic Fusion Protein CBFB-SMMHC Downregulates CD48 to Evade NK Cell Recognition

Shlomo Elias, MD PhD, Dorin Shreibman, MSc, Tamar Unger, PhD, Shira Kahlon, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3913.
https://doi.org/10.1182/blood.V130.Suppl_1.3913.3913
Published: 2017
Journal Articles

Obinutuzumab Activates CD64 More Potently Than Other Anti-CD20 Antibodies in Chronic Lymphocytic Leukemia (CLL)

Shlomo Elias, MD PhD, Shira Kahlon, PhD, Rebecca Kotzur, B.Sc., Noah Kaynan, PhD, Ofer Mandelboim, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3022.
https://doi.org/10.1182/blood.V130.Suppl_1.3022.3022
Published: 2017
Journal Articles

Immune evasion by oncogenic proteins of acute myeloid leukemia

Shlomo Elias, Rachel Yamin, Lior Golomb, Pinchas Tsukerman, Noah Stanietsky-Kaynan, Dina Ben-Yehuda, Ofer Mandelboim
Journal: Blood
Blood (2014) 123 (10): 1535–1543.
https://doi.org/10.1182/blood-2013-09-526590
Published: 2014
Includes: Supplemental data